Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-24

Clinical Trial Update: Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty [NA]

View source ↗

Summary

Results from a clinical trial of rivaroxaban (Xarelto) for thromboprophylaxis after total hip and total knee arthroplasty have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xarelto (rivaroxaban)

Snippet

Sponsor: Chiayi Christian Hospital | Conditions: Venous Thromboembolism, Arthroplasty | NA | Status: COMPLETED | Results posted: 2026-04-24